For 40 years, we have been developing, manufacturing and marketing branded generic medicines in the MENA region. We supply quality branded generics to 17 markets and have a proven track record with in-licensors. We are also building our injectable medicines business in the territory. Our long-standing presence in the MENA has made us the fifth largest pharmaceutical manufacturer in the region and we have US FDA inspected facilities in Jordan and Saudi Arabia.
Our products
We have a broad range of quality medicines and a growing pipeline of new, differentiated products.
Careers
We’re committed to our employees, our customers and the people they serve. Could you support one of our teams?
Related news
Hikma has launched Ritonavir Tablets USP
20 March 2018
Hikma announces global partnership with Direct Relief
15 March 2018